Literature DB >> 15251148

Pulmonary pathology.

Daphne E deMello1.   

Abstract

Common causes of neonatal respiratory distress include meconium aspiration, pneumonia, persistent pulmonary hypertension of the newborn, pneumothorax and cystic adenomatoid malformation. Genomics and proteomics have enabled the recent recognition of several additional disorders that lead to neonatal death from respiratory disease. These are broadly classified as disorders of lung homeostasis and have pathological features of proteinosis, interstitial pneumonitis or lipidosis. These pathological changes result from inherited disorders of surfactant proteins or granulocyte-macrophage colony stimulating factor. Abnormal lung vascular development is the basis for another cause of fatal neonatal respiratory distress, alveolar capillary dysplasia with or without associated misalignment of veins. Diagnosis of these genetically transmitted disorders is important because of the serious implications for future siblings. There is also a critical need for establishing an archival tissue bank to permit future molecular biological studies. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251148     DOI: 10.1016/j.siny.2003.12.001

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  9 in total

1.  Mesodermal Pten inactivation leads to alveolar capillary dysplasia- like phenotype.

Authors:  Caterina Tiozzo; Gianni Carraro; Denise Al Alam; Sheryl Baptista; Soula Danopoulos; Aimin Li; Maria Lavarreda-Pearce; Changgong Li; Stijn De Langhe; Belinda Chan; Zea Borok; Saverio Bellusci; Parviz Minoo
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

2.  The Hsp90 cochaperone p23 is essential for perinatal survival.

Authors:  Iwona Grad; Thomas A McKee; Sara M Ludwig; Gary W Hoyle; Patricia Ruiz; Wolfgang Wurst; Thomas Floss; Charles A Miller; Didier Picard
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

3.  Misplaced pulmonary arteries in an adult patient with pulmonary hypertension.

Authors:  G B Marshall; C I S Silva; J C English; R D Levy; N L Müller
Journal:  Br J Radiol       Date:  2010-01       Impact factor: 3.039

4.  FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network.

Authors:  Andrew C White; Kory J Lavine; David M Ornitz
Journal:  Development       Date:  2007-09-19       Impact factor: 6.868

5.  Effects of palmitoylation on dynamics and phospholipid-bilayer-perturbing properties of the N-terminal segment of pulmonary surfactant protein SP-C as shown by 2H-NMR.

Authors:  Azucena Gonzalez-Horta; David Andreu; Michael R Morrow; Jesús Perez-Gil
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

6.  Segregated phases in pulmonary surfactant membranes do not show coexistence of lipid populations with differentiated dynamic properties.

Authors:  Jorge Bernardino de la Serna; Greger Orädd; Luis A Bagatolli; Adam C Simonsen; Derek Marsh; Göran Lindblom; Jesus Perez-Gil
Journal:  Biophys J       Date:  2009-09-02       Impact factor: 4.033

Review 7.  Surface tension in human pathophysiology and its application as a medical diagnostic tool.

Authors:  Anahita Fathi-Azarbayjani; Abolghasem Jouyban
Journal:  Bioimpacts       Date:  2015-02-28

8.  Simulations demonstrate a simple network to be sufficient to control branch point selection, smooth muscle and vasculature formation during lung branching morphogenesis.

Authors:  Géraldine Cellière; Denis Menshykau; Dagmar Iber
Journal:  Biol Open       Date:  2012-06-27       Impact factor: 2.422

9.  Gene expression profiling of postnatal lung development in the marsupial gray short-tailed opossum (Monodelphis domestica) highlights conserved developmental pathways and specific characteristics during lung organogenesis.

Authors:  Vengamanaidu Modepalli; Amit Kumar; Julie A Sharp; Norman R Saunders; Kevin R Nicholas; Christophe Lefèvre
Journal:  BMC Genomics       Date:  2018-10-05       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.